Rapid Growth Of HER-2 Negative Breast Cancer Treatment Options

https://www.coherentmarketinsights.com/market-insight/her-2-negative-breast-cancer-market-5622
HER-2 Negative Breast Cancer Market



HER-2 negative breast cancer is a type of breast cancer that does not have high levels of the human epidermal growth factor receptor 2 (HER2) protein. HER-2 negative breast cancer represents around 70% of all breast cancer cases. Effective treatment options such as chemotherapy, surgery, radiation therapy and hormonal therapy are being increasingly used to inhibit the growth and recurrence of HER-2-negative breast cancer.


HER-2 negative breast cancer negatively impacts women's health and significantly reduces life expectancy if not treated on time. Treatment options involving chemotherapy, hormonal therapy and targeted therapy are being effectively utilized to inhibit tumor growth, reduce recurrence and improve survival rates.

The global HER-2 Negative Breast Cancer Market is estimated to be valued at US$ 13,873.7 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rapid growth is being driven by rising healthcare awareness and increasing use of targeted therapy drugs in combination with other treatment options. New drug approvals by regulatory authorities are further fueling the market growth. For instance, Pfizer's Ibrance was approved by FDA in 2015 for combination use with hormonal therapy in HER-2 negative breast cancer treatment. Eli Lilly and Company's Verzenio was also approved in 2017, creating new opportunities that are benefiting patients. Furthermore, ongoing research for developing novel therapies will continue boosting market revenues over the forecast period.
Segment Analysis

The global HER-2 negative breast cancer market is segmented on the basis of drug class, end-user and distribution channel. Based on drug class, the market is segmented into chemotherapy, targeted therapy, and others. The chemotherapy drug class segment dominated the market in 2022 owing to the high adoption and availability of generic chemotherapy drugs. However, the targeted therapy segment is expected to witness highest growth over the forecast period due to rising approval and uptake of novel targeted therapies for HER-2 negative breast cancer treatment.

Key Takeaways

The global HER-2 Negative Breast Cancer Market Growth is expected to witness high growth over the forecast period. The North America region currently dominates the market due to factors such as high cancer incidence rates, rising healthcare expenditure and presence of key market players in the region. However, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. This is attributed to growing awareness, improving healthcare infrastructure and increasing healthcare spending in emerging economies such as India and China.

Regional analysis
Asia Pacific region is projected to grow at the highest CAGR during the forecast period. Growing awareness regarding early diagnosis and treatment availability, increasing government funding for cancer research and rising healthcare expenditure are some of the factors fueling market growth in the region. Improvement in healthcare infrastructure along with increasing accessibility of medical facilities in emerging countries is also expected to boost market growth in Asia Pacific during the forecast period.

Key players
Key players operating in the HER-2 negative breast cancer market are Pfizer Inc., Novartis AG, Merck & Co. Inc., GSK PLC, AstraZeneca, Eli Lilly and Company, and Bristol-Myers Squibb Company (Celgene Corporation), among others.

Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more